Ocugen Inc. and Bharat Biotech on Thursday (June 3, 2021) announced that they have entered into an amendment to their Co-development, Supply, and Commercialization Agreement to expand Ocugen's exclusive territory to commercialize Covaxin.
https://ift.tt/eA8V8J from https://ift.tt/3wWFUKQ
ليست هناك تعليقات:
إرسال تعليق